RE:RE:RE:RE:RE:RE:RE:Merck USA (MSD) acquires Phase 2 biotech for US$ 10.8 Bln.A predictive diagnostic helps in determining which of a set of patients will benefit from a particular therapeutic. (i.e. companion diagnostic for Herceptin in breast cancer therapy)
https://www.onclive.com/view/fda-approves-companion-diagnostic-for-trastuzumab-in-her2-breast-cancer
A prognostic diagnostic helps advise whether the drug is still working in a patient after the patient has been taking the drug therapy for a period of time.
Together a predictive and prognostic diagnostic are designed to fullfill the predictiveness and performance a therapy in the field of "precision medicine", which is defined as treating the right patient, at the right time, with the right drug or combination of drugs, like ONCY's pelareorep in combination with immune checkpoint inhibitors.
ONCY's AWARE-1 study has resulted in the discovery of a set of biomarkers that facilitate in the predictive / prognostic activity of ONCY's pelareorep in combination with PD-(L)1 immune checkpoint inhibitors, such a Roche's atezolizumab, for example.